Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytokine-enhanced cytolytic activity of exosomes from NK Cells. | Cancer Gene Ther | 2022 | 34316033 | PubTator, text mining | PubMed |
| Prognostic importance of expression of mini-chromosome maintenance proteins (MCMs) in patients with nasopharyngeal cancer treated with curative radiotherapy. | Braz J Otorhinolaryngol | 2022 | 34144903 | PubTator, text mining | PubMed |
| Transcriptome Sequencing Reveals Key Genes in Three Early Phases of Osteogenic, Adipogenic, and Chondrogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Rats. | Front Mol Biosci | 2021 | 35223983 | PubTator, text mining | PubMed |
| Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma. | Front Pharmacol | 2021 | 35173608 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis to identify key genes related to the prognosis of esophageal squamous cell carcinoma. | Transl Cancer Res | 2021 | 35116493 | PubTator, text mining | PubMed |
| Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. | Front Immunol | 2021 | 35069553 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice. | Front Immunol | 2021 | 35069545 | PubTator, text mining | PubMed |
| BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10. | Pharmaceuticals (Basel) | 2021 | 35056094 | PubTator, text mining | PubMed |
| Synergistic effects of methyl 2-cyano-3,11-dioxo-18beta-olean-1,-12-dien-30-oate and erlotinib on erlotinib-resistant non-small cell lung cancer cells. | J Pharm Anal | 2021 | 35028186 | PubTator, text mining | PubMed |
| Prognostic significance of MCM6 expression in gastrointestinal stromal tumor. | Int J Clin Exp Pathol | 2021 | 35027992 | PubTator, text mining | PubMed |
| Telomerase Interaction Partners-Insight from Plants. | Int J Mol Sci | 2021 | 35008793 | PubTator, text mining | PubMed |
| MCM2-7 in Clear Cell Renal Cell Carcinoma: MCM7 Promotes Tumor Cell Proliferation. | Front Oncol | 2021 | 34993142 | PubTator, text mining | PubMed |
| Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases. | Front Pharmacol | 2021 | 34987381 | PubTator, text mining | PubMed |
| Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma. | Biomed Res Int | 2021 | 34961841 | PubTator, text mining | PubMed |
| Genomic Insights Into the Genetic Structure and Natural Selection of Mongolians. | Front Genet | 2021 | 34956310 | PubTator, text mining | PubMed |
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells. | Cancers (Basel) | 2021 | 34944881 | PubTator, text mining | PubMed |
| An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (MSH6) in human tumors. | Aging (Albany NY) | 2021 | 34941572 | PubTator, text mining | PubMed |
| Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma. | Front Immunol | 2021 | 34925377 | PubTator, text mining | PubMed |
| Systems biology analysis of human genomes points to key pathways conferring spina bifida risk. | Proc Natl Acad Sci U S A | 2021 | 34916285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=26